Results from Optimizing Beta-Blocker Dosage in Female Patients Using the Wearable Cardioverter Defibrillator (OPT-BB Women) were presented at ESC-HF 2026 ZOLL®, an Asahi Kasei company that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results